WANG Jianyou, ZHENG Min, YAN Jianliang, LIU Lunfei, CHEN Jisu. Serum Levels of Chemokines in the Patients With Systemic Lupus Erythematosus[J].Chinese Journal of Dermatology, 2002, 35(1): 20-21.
[1] Bombardier C, Gladman DD, Urowitz MB, et al. Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE. Arthritis Rheum, 1992,35:630-640. [2] 郑敏,朱铁城. SLE患者 B淋巴细胞增殖功能测定及其临床意义. 中华皮肤科杂志,1990,23:90-92. [3] Noris M, Bernasconi S, Casiraghi F, et al. Monocyte chemoattractant protein-1 is excreted in excessive amounts in the urine of patients with lupus nephritis. Lab Invest, 1995,73:804-809. [4] Wada T, Yokoyama H, Su SB, et al. Monitoring urinary levels of monocyte chemotactic and activating factor reflects disease activity of lupus nephritis. Kidney Int, 1996,49:761-767. [5] Kaneko H, Ogasawara H, Naito T, et al. Circulating levels of beta chemokines in systemic lupus erythematosus. J Rheumatol, 1999,26:568-573.